From Globe Newswire: 2025-05-22 10:10:00

The global Exosomes Market was valued at $136.16 million in 2023, expected to reach $1,311.03 million by 2032 with a CAGR of 28.62%. Increased funding and technological advancements are driving growth, particularly in oncology and neurology. Major players include Thermo Fisher Scientific and Codiak BioSciences.

In the United States, the Exosomes market reached $41.77 million in 2023, projected to hit $399.74 million by 2032 with a CAGR of 28.53%. Strong support from NIH and FDA, along with collaborations between academia and industry, are driving this growth. Key players in the market include Aethlon Medical and Bio-Techne Corporation.

In 2023, Kits & Reagents held the largest share of the Exosomes product market at 55%. Cancer was the leading indication at 40.5%, while biomarkers accounted for 48.7% of the market in applications. Pharmaceutical & Biotechnology Companies held 55.2% market share in end users. North America accounted for 41.7% of global revenue in 2023, led by the United States. The exosomes market is experiencing rapid growth due to high funding levels, a robust clinical trials pipeline, and early adoption of precision medicine technologies. Asia Pacific is emerging as a key region, with increasing investments in regenerative medicine and biotech industries. Recent developments include promising preclinical results and early-phase human trials for exosome-based treatments.

Key players in the exosomes market are prioritizing oncology therapeutics after positive outcomes, driving market dominance. Asia Pacific is set to be the fastest-growing region, with local companies investing in R&D. Evox Therapeutics, Aethlon Medical, and Codiak BioSciences have made significant advancements in exosome-based treatments for various disorders.

To keep pace with the rapidly evolving exosomes market, companies are focusing on oncology therapeutics and expanding into Asia Pacific regions. Evox Therapeutics, Aethlon Medical, and Codiak BioSciences are leading the way with innovative exosome-based treatments. High investments and collaborations are driving market growth and commercialization efforts.



Read more at Globe Newswire: Exosomes Market Projected to Reach USD 1,311.03 Million by